Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Tonge

Showing results (21-30 of 169) with videos related to

Pageof 17
Sort By:
Bioorganic Chemistry|February 7, 2006
A Raman-active competitive inhibitor of OMP decarboxylaseBrian P Callahan, Alasdair F Bell, Peter J Tonge, et al.
Biochemistry|January 24, 2007
Structure and mechanism of MbtI, the salicylate synthase from Mycobacterium tuberculosisJacque Zwahlen, Subramaniapillai Kolappan, Rong Zhou, et al.
Protein Science : a Publication of the Protein Society|June 30, 2007
Probing mechanisms of resistance to the tuberculosis drug isoniazid: Conformational changes caused by inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosisNicole A Kruh, Richa Rawat, Béla P Ruzsicska, et al.
Current Topics in Medicinal Chemistry|March 10, 2007
FtsZ: a novel target for tuberculosis drug discoveryQing Huang, Peter J Tonge, Richard A Slayden, et al.
Biochemistry|May 28, 2011
Elucidation of the protonation states of the catalytic residues in mtKasA: implications for inhibitor designWook Lee, Sylvia R Luckner, Caroline Kisker, et al.
Biochemistry|April 16, 2003
Structure-activity studies of the inhibition of FabI, the enoyl reductase from Escherichia coli, by triclosan: kinetic analysis of mutant FabIsSharada Sivaraman, Jacque Zwahlen, Alasdair F Bell, et al.
Journal of the American Chemical Society|June 5, 2003
Light-driven decarboxylation of wild-type green fluorescent proteinAlasdair F Bell, Deborah Stoner-Ma, Rebekka M Wachter, et al.
Organic Letters|December 17, 2016
Stereoselective Synthesis, Docking, and Biological Evaluation of Difluoroindanediol-Based MenE Inhibitors as AntibioticsChristopher E Evans, Joe S Matarlo, Peter J Tonge, et al.
ACS Infectious Diseases|February 4, 2020
Correlating Drug-Target Residence Time and Post-antibiotic Effect: Insight into Target VulnerabilityShabnam Davoodi, Fereidoon Daryaee, Andrew Chang, et al.
Microbial Pathogenesis|June 6, 2026
The post antibiotic effect of streptogramins on Gram-positive bacteria primarily arises from the type A componentAya K Sabbah, Brandon M Thrope, Stephen G Walker, et al.
Pageof 17

Showing results (21-30 of 169) with videos related to

Sort By:
Pageof 17
Bioorganic Chemistry|February 7, 2006
A Raman-active competitive inhibitor of OMP decarboxylaseBrian P Callahan, Alasdair F Bell, Peter J Tonge, et al.
Biochemistry|January 24, 2007
Structure and mechanism of MbtI, the salicylate synthase from Mycobacterium tuberculosisJacque Zwahlen, Subramaniapillai Kolappan, Rong Zhou, et al.
Protein Science : a Publication of the Protein Society|June 30, 2007
Probing mechanisms of resistance to the tuberculosis drug isoniazid: Conformational changes caused by inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosisNicole A Kruh, Richa Rawat, Béla P Ruzsicska, et al.
Current Topics in Medicinal Chemistry|March 10, 2007
FtsZ: a novel target for tuberculosis drug discoveryQing Huang, Peter J Tonge, Richard A Slayden, et al.
Biochemistry|May 28, 2011
Elucidation of the protonation states of the catalytic residues in mtKasA: implications for inhibitor designWook Lee, Sylvia R Luckner, Caroline Kisker, et al.
Biochemistry|April 16, 2003
Structure-activity studies of the inhibition of FabI, the enoyl reductase from Escherichia coli, by triclosan: kinetic analysis of mutant FabIsSharada Sivaraman, Jacque Zwahlen, Alasdair F Bell, et al.
Journal of the American Chemical Society|June 5, 2003
Light-driven decarboxylation of wild-type green fluorescent proteinAlasdair F Bell, Deborah Stoner-Ma, Rebekka M Wachter, et al.
Organic Letters|December 17, 2016
Stereoselective Synthesis, Docking, and Biological Evaluation of Difluoroindanediol-Based MenE Inhibitors as AntibioticsChristopher E Evans, Joe S Matarlo, Peter J Tonge, et al.
ACS Infectious Diseases|February 4, 2020
Correlating Drug-Target Residence Time and Post-antibiotic Effect: Insight into Target VulnerabilityShabnam Davoodi, Fereidoon Daryaee, Andrew Chang, et al.
Microbial Pathogenesis|June 6, 2026
The post antibiotic effect of streptogramins on Gram-positive bacteria primarily arises from the type A componentAya K Sabbah, Brandon M Thrope, Stephen G Walker, et al.
Pageof 17